Selected Publications By the Members of the MSS (2003)

  1. Azzola MF, Shaw HM, Thompson JF, Soong S-j, Scolyer RA, Watson GF, Colman MH, Zhang Y. Tumor Mitotic Rate is a More Powerful Prognostic Indicator than Ulceration in Patients with Primary Cutaneous Melanoma. An Analysis of 3661 Patients from A single Center. Cancer 97(6):1488-1498, 2003.
  2. Balch CM, Houghton AN, Sober AJ, Soong-Sj (Eds), Cutaneous Melanoma (Fourth Edition), Quality Medical Publishing, Inc., St. Louis, MO, 2003.
  3. Balch CM, Gershenwald JE, Buzaid A, Cascinelli N, Soong S-j : Staging and Classification of Melanoma in Cutaneous Melanoma 55-76, 2003. Balch CM, Houghton AN, Sober AJ, Soong S-j, eds. Quality Medical Publishing, Inc., St. Louis, Kimberlin DW, Lin C-Y, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong S-j, Whitley RJ, and the National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. Effect of Ganciclovir Therapy on Hearing in Symptomatic Congenital Cytomegalovirus Disease Involving the Central Nervous System: A Randomized, Controlled Trial. The Journal of Pediatrics, July:16-25, 2003.
  4. Desmond RA , Soong S-j: Epidemiology of Malignant Melanoma. Surgical Clinics of North America 83:1-29, 2003.
  5. Gershenwald JE, Balch CM, Soong S-j , Thompson JF : Prognostic Factors and Natural History of Melanoma in Cutaneous Melanoma 25-54, 2003 . Balch CM, Houghton AN, Sober AJ, Soong S-j, eds. Quality Medical Publishing, Inc., St. Louis , 2003.
  6. Kimberlin DW, Lin C-Y, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong S-j, Whitley RJ, and the National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. Effect of Ganciclovir Therapy on Hearing in Symptomatic Congenital Cytomegalovirus Disease Involving the Central Nervous System: A Randomized, Controlled Trial. The Journal of Pediatrics, July:16-25, 2003.
  7. Soong S-j, Zhang Y , Desmond RA. Model for Predicting Outcomes in Cutaneous Melanoma. Balch CM, Houghton AW, Sober AJ, Soong S-j, Eds.Quality Medical Publshing, St. Louis, MO, 2003.
  8. Spencer S, Wheeler R, Peters G, Meredith R, Beenken S, Nabel L, Wooten A, Soong Sj, Salter M. Phase I Trial of Combined Chemotherapy and Reirradiation for Recurrent Unresectable Head and Neck Cancer. Head and Neck Surgery 25(2):118-122, 2003.
  9. Carey D , Bae S, Shanmugam R, Bartolucci AA, Singh KP. Assessing Therapeutic Equivalence of Three Proportions Using Weighted Likelihood Ratio and Equivalence Cube. International Congress of Modeling and Simulation, July 14-17, 2003. Townsville, AU.
  10. Haviv YS, Takayama K, Nagi PA, Tousson A, Cook W, Wang M, Lam JT, Naito S, Lei X, CareyDE, Curiel DT. Modulation of Renal Glomerular Disease Using Remote Delivery of Adenoviral-encoded Solubletype II TGF-beta Receptor Fusion Molecule. J Gene Med. 10: 839-51, 2003.
  11. Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh, Doublas JT. The Coxsackievirus and Adenovirus Receptor Acts as a Tumour Suppressor in Malignant Glioma Cells. British Journal of Cancer 88:1411-1416, 2003.
  12. Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Curiel DT. Intravenous Delivery of Adenovirus-mediated sFLT-1 Results in Liver Toxicity. Clinical Cancer Research, 9(7), 2003.
  13. Meredith RF, Shen S, Macey D, Khazaeli MB, Carey D, Robert F, and LoBuglio A. A Comparison of Biodistribution, Dosimetry and Outcome from Clinical Trials of Radionuclide-CC49 Antibody Therapy. Cancer Biotherapy 18(3):393-404, 2003.
  14. Robert F, Busby E, Marques MB, Reynolds RE, Carey D. Phase II Study of Docetaxel Enoxaparin in Chemotherapy-Naïve Patients with Metastatic Non-Small Cell Lung Cancer: Preliminary Results. Lung Cancer 42, 237-245, 2003.
  15. Buchsbaum DJ, Zhou T, Grizzle WE, Oliver PG, Hammond CJ, Zhang S, Carpenter M, LoBuglio AF. Antitumor efficacy of TRA-8 anti DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res 9(10.1):3731-41, 2003.
  16. Forero A, Meredith RF, Khazaeli MB, Carpenter DM, Shen S, Thornton J, Schlom J, LoBuglio AF. A novel monoclonal antibody design for radioimmunotherapy. Cancer Biother Radiopharm 18(5):751-9, 2003.
  17. Neidhart J, Allen KO, Barlow DL, Carpenter M, Shaw DR, Triozzi PL, Conroy RM. Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA without granulocyte-macrophage colony-simulating factor. Vaccine 22(5-6):774-81, 2003.
  18. Posey JA, Ng TC, Yang B, Khazeli MB, Carpenter MD, Fox F, Needle M, Waksal H, LoBuglio AF. A phase I study of anti-kinase insert domain-containing receptor antibody IMC-1C11 in patients with liver metastases from colorectal carcinoma. Clin Cancer Res 9(4):1323-32, 2003.
  19. Safavy A, Bonner JA, Waksal HW, Buchsbaum DJ, Gillespie GY, Khazaeli MB, Arani R, Chen DT, Carpenter M, Raisch KP. Synthesis and Biological Evaluation of Paclitaxel-C225 Conjugate as a Model for Targeted Drug Deliver. Bioconjugate Chemistry 14:302-310, 2003.
  20. Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, and Lin SH. Antitumor Activity of the 16-kDa Prolactin Fragment in Prostate Cancer. Cancer Research 63:386-93, 2003.
  21. Abzug MJ, Cloud GA, Bradley J, Sanchez P, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley R, Kimberlin DW. Double-blind, Placebo-controlled Trial of Pleconaril in Infants with Enterovirus Meningitis. Pediatric Infectious Diseases Journal 22:335-40, 2003.
  22. Rinehart JJ, Keville L, Neidhart J, Wong L, DiNunno L, Kinney P, Aberle M, Tadlock L, Cloud G. Hematopoietic Protection by Dexamethasone or Granulocyt Macrophage Colony Stimulating Factor (GM-CSF) in Patients Treated with Carboplatin and Ifosfamide. Am Journal Oncology 26(5);448-58, Oct. 2003.
  23. Bachmann LH, Pigott D, Desmond R, Jones M, Lumpkins J, Gla P, Tendrop T, Hook EW. Prevalence and Factors Associated with Gonorrhea and Chlamydia in Females Presenting to an Urban Emergency Department. Sexually Transmitted Disease 30:335-339, 2003.
  24. Beenken SW, Urist MM, Zhang Y, Desmond R, Krontiras H, Medina H. Bland KI. Axillary Lymph Node Status, but not Tumor Size, Predicts Locoregional Recurrence and Overall Survival after Mastectomy for Breast Cancer. Annals of Surgery 5:732-739, 2003.
  25. Byrne NM, Weinsier FL, Hunter GR, Desmond R, Patterson NA, Darnell BE, Zuckerman PA. Distribution of Lean and Fat Mass Following Weight Loss and Weight Regain: Comparison of Responses of White and Black Women. Am J Clin Nutr 77:1368-73, 2003.
  26. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal Trends (1973-1977) in Survival of Patients with Esophageal Adenocarcinoma in the United States: A Glimmer of Hope? American Journal of Gastroenterology 98:1627-33, 2003.
  27. Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female Gender and Other Factors Predictive of a Limited Screening Flexible Signoidoscopy Examination for Colorectal Cancer. American Journal of Gastroenterology 98:1634-1639, 2003.
  28. Guay-Woodford L, Desmond RA. Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America. Pediatrics 111:1072-1080, 2003.
  29. Hemminki A, Wang M, Hakkarainen T, Desmond RA, Wahlfors JJ, Curiel DT. Production of EGFR Targeting Molecule from a Conditionally Replicating Adenovirus Impairs its Oncolytic Potential. Cancer Gene Therapy 10:583-88, 2003.
  30. Hemminki A, Kanerva A, Kremer EJ, Bauerschmitz GJ, Smith BF, Liu B, Wang M, Desmond RA, Keriel A, Barnett B, Baker HJ, Siegal GP, Curiel DT. A Canine Replicating Adenovirus for Evaluating Oncolytic Virotherapy in a Syngenic Animal Model. Mol Ther 7:163-173, 2003.
  31. Oh MK, Schwebke J, Desmond R, Merchant J, Brown D, Jones M, Simpson T, Funkhouser E. Predictors of Bacterial Vaginosis in Young Women who Douche. J Adolesc Health 32(2):129-130, 2003.
  32. Rosenthal EB, Schrenniras S, Peters GE, Grizzle W, Desmond R, Gladson C. Expression of EMMPRIN in Laryngeal Squamous Cell Carcinoma. Laryngoscope 113:1406:1410, 2003.
  33. Hill A and Kim H. The UAB Proteomics Database. Bioinformatics 16, November 1, 2003.
  34. Louro ID, Bailey EC, Li X, South LS, McKieBell PR, Yoder BK, Huang CC, Johnson MR, Hill AE, Johnson RL and Ruppert JM: Comparative Gene Expression Profile Analysis of GLI and c-MYC in an Epithelial Model of Malignant Transformation. Cancer Res, Oct. 15, 2003.
  35. Bennett JE, Kauffman C, Walsh T, dePauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Lee J, Papps P, Power J, Rex J, Verweij P, Viscoli C. Forum Report: Issues in the Evaluation of Diagnostic Tests, Use of Historical Controls and Merits of the Current Multicenter Collaborative Groups. Clinical Infectious Diseases 36 (Suppl 3):S123-7, 2003.
  36. Bennett JE, Power J, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Viscoli C, Walsh T. Forum Report: Issues in Clinical Trials Drugs for the Treatment of Invasive Aspergillosis. Clinical Infectious Diseases 36 (Suppl 3):S113-16, 2003.
  37. Bennett JE, Power J, Walsh T, Viscoli C, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P. Forum Report: Issues in Clinical Trials of Empirical Antifungal Therapy in Treating Febrile Neutropenic Patients. Clinical Infectious Diseases 36 (Suppl 3):S117-22, 2003.
  38. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE and the NIAID Mycoses Study Group. A Prospective Observational Study of Candidemia: Epidemiology, Therapy and Influences on Mortality in Hospitalized Adult and Pediatric Patients. Clinical Infectious Diseases 37(5):634-43, 2003.
  39. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edward JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Robin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu T-C, Panzer H, Rosenstein RB, Booth J for the NIAID Mycoses Study Group. A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole Plus Placebo Versus Fluconazole Plus Amphoticin B as Therapy for Candidemia and its Consequences in Nonneutropenic Subjects. Clinical Infectious Diseases 36:1221-1228, 2003.
  40. Dasanayake AP, Li Y, Kirk K, Bronstein J, Childers NK. Restorative Cost Savings Related to Dental Sealants in Alabama Medicaid Children. Pediatr Den. 25(6), 572-6, 2003.
  41. Li F, Michalek SM, Dasanayake AP, Li Y, Kirk K, Childres NK. Intranasal Immunization of Human with Streptococcus Mutans Antigens. Oral Microbiology Immunology 18:1-7, 2003.
  42. Ling B, Santiago ML, Meleth S, Gormus B, McClure H, Apetrei C, Hahn BH, Marx PA. Non-Invasive Detection of New Simian Immunodeficiency Virus Lineages in Captive Sooty Mangabeys: Ability to Amplify Virion RNA from Fecal Samples Correlates with Viral Load in Plasma. Journal of Virology 77(3):2214-2226, 2003.
  43. Carroll WR, Rosenstiel D, Fix JR, de la Torre J, Solomon JS, Brodish B, Rosenthal EL, Peters GE, Heinz T, Niwas S: Three Dose vs. Extended Course Clindamycin Prophylaxis for Free-Flap Reconstruction of the Head and Neck. Archives of Otolaryngology Head and Neck Surgery 129(7):771-774, 2003.
  44. Chung BH, Doran S, Liang P, Osterlund L, Cho BHS, Oster RA , Darnell B, Franklin F. Alcohol-mediated Enhancement of Postprandial Lipemia: A Contributing Factor to an Increase in Plasma HDL and a Decrease in Risk of Cardiovascular Disease. The American Journal of Clinical Nutrition 78:391-399, 2003.
  45. Jones AR, Thompson CJ, Oster RA, Samadi A, Davis MK, Mayberry RM. Breast Cancer Knowledge, Beliefs, and Screening Behaviors Among Low-income, Elderly Black Women. Journal of the National Medical Association 95:791-805, 2003.
  46. Oster RA . An Examination of Statistical Software Packages for Categorical Data Analysis Using Exact Methods – Part II. The American Statistician 57:201-213, 2003.
  47. Oster RA . Comment on “Comparing Statistical Software Packages: The Case of the Logrank Test in StatXact” by H. Callaert. The American Statistician 57:224-225, 2003.
  48. Bonner AB, Monroe KW, Talley LI,Klasner AE, Kimberlin DW. Impact of the Rapid Diagnosis of Influenza on Physician Decision-making and Patient Management in the Pediatric Emergency Department: Results of a randomized, prospective controlled trial. Pediatrics 112(2):363-7, 2003.
  49. Chhieng DC, Rodriguez-Burford C, Talley LI, Sviglin H, Stockard CR, Kleinberg MJ, Barnes MN, Partridge EE, Grizzle WE. Expression of CEA, Tag-72, and Lewis-Y Antigen in Primary and Metastatic Lesions of Ovarian Carcinoma. Human Path 34(10):1016-21, 2003.
  50. Chhieng DC, Tabbara SO, Marley EF, Talley LI, Frost AR. Microvessel Density and Vascular Endothelial Growth Factor Expression in Infiltrating Lobular Mammary Carcinoma. Breast J. 9(3):200-7, 2003.
  51. Rodriguez-Burford C, Oelschlager DK, Talley LI, Barnes MN, Partridge EE, Grizzle WE. The Use of Dimethyl Sulfoxide (DMSO) as a Vehicle in Cell Culture Experiments Using Ovarian Carcinoma Cell Lines. Biotechnic and Histochemistry 78(1):17-21, 2003.
  52. Sheffield MV, Simsir A, Talley LI, Roberson AJ, Elgert PA, Chhieng DC. Interobserver Variability in Assessing Adequacy of the Squamous Component in Conventional Cervicovaginal Smears. American Journal of Clinical Pathology 119(3):367-73, 2003.
  53. Simsir A, Hwang S, Cangiarella J, Elgert P, Levine P, Sheffield MN, Roberson J, Talley LI, Chhieng DC. Glandular Cell Atypia on Papanicolaou Smears: Interobserver Variability in the Diagnosis and Prediction of Cell of Origin. Cancer 99(6):323-30, 2003.
  54. Dorak MT, Tang J, Tang S, Penman-Aguilar A, Coutinho R, Goedert J, Detels R and Kaslow RA. Influence of Human Leukocyte Antigen-b22 alleles on the Course of Human Immunodeficiency Virus Type I Infection in 3 Cohorts of White Men. J Infec Dis 188(6):856-63, Sept. 15, 2003.
  55. Lobashevsky ES, Dorak MT, Tang J, Tang S, Zulu I, Allen S, Kaslow RA. MICA Exon 5 Short Tandem Repeat Polymorphism and HLA Haplotypes in Zambians. Hum Immunol 64(10 Suppl):S176, October 2003.
  56. Telfair J, Haque A, Etienne M, Tang S, Strasser S. Rural/Urban Differences in Access to and Utilization of Services Among People in Alabama with Sickle Cell Disease. Public Health Rep 118(1):27-36, 2003.
  57. Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Call S, Saag MS. Duration of Highly Active Antiretroviral Therapy Regimens. Clinical Infectious Diseases 37(5):714-22, 2003.
  58. Balch CM, Soong S-j, and AJCC Melanoma Staging Committee. New TNM Melanoma Staging System: Linking Biology and Natural History to Clinical Outcomes. Seminars in Surgical Oncology 21(1):43-52, 2003.
  59. Tu SM, Millikan RE, Pagliaro LC, Daliani D, Papandreou CN, Kim J, Chen DT, Williams D, Logothetis CJ. Treatment of Refractory Urothelial Carcinoma with Alternating Paclitaxel, Methotrexate, Cisplatin (TMP) and 5-Fluorouracil, Alpha-Interferon, Cisplatin. Urologic Oncology Journal 21(5):342-8, 2003.
  60. Jhala N, Montemor M. Jhala D, Talley LI, Lu L, Haber M et al. Pancreatic Metaplasia in Autoimmune Gastritis. Archives of Pathology in Laboratory Medicine 127(7):854-7, 2003.